Latest Period
Q4 2025
Security Snapshot
Cellectar Biosciences, Inc. - Common Shares (CLRB) Institutional Ownership
CUSIP: 15117F880
13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025
Institutions Reporting
19
Shares (Excl. Options)
336,454
Price
$2.95
- Type / Class
- Equity / Common Shares
- Symbol
- CLRB on Nasdaq
- Shares outstanding
- 4,338,395
- Price per share
- $2.76
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 336,454
- Total reported value
- $992,540
- % of total 13F portfolios
- 0%
- Share change
- +50,684
- Value change
- -$210
- Number of holders
- 19
- Price from insider filings
- $2.76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CLRB - Cellectar Biosciences, Inc. - Common Shares is tracked under CUSIP 15117F880.
- 19 institutions reported positions in Q4 2025.
- 5 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 21 to 19 between Q3 2025 and Q4 2025.
- Reported value moved from $1,650,372 to $992,540.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 15117F880?
CUSIP 15117F880 identifies CLRB - Cellectar Biosciences, Inc. - Common Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15117F880:
Significant Owners of Cellectar Biosciences, Inc. - Common Shares (CLRB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Hexstone Capital LLC | 4.9% | -12% | $553,293 | +$169,293 | 216,130 | +44% | Hexstone Capital LLC | 31 Dec 2025 |
| Bleichroeder LP | 4.6% | -24% | $760,000 | 200,000 | 0% | Bleichroeder LP | 31 Dec 2025 | |
| INTRACOASTAL CAPITAL, LLC | 5% | 140,101 | Mitchell P. Kopin | 01 Jul 2025 | ||||
| LYTTON LAURENCE W | 1.6% | $250,788 | 51,391 | LYTTON LAURENCE W | 30 Jun 2025 | |||
| Nantahala Capital Management, LLC | 0.06% | $5,412 | 1,109 | Nantahala Capital Management, LLC | 30 Jun 2025 |
As of 31 Dec 2025, 19 institutional investors reported holding 336,454 shares of Cellectar Biosciences, Inc. - Common Shares (CLRB). This represents 7.8% of the company’s total 4,338,395 outstanding shares.